共 101 条
[1]
Sebag J(2002)Is pharmacologic vitreolysis brewing? Retina 22 1-3
[2]
Rheaume MA(2010)Pharmacologic vitreolysis Semin Ophthalmol 25 295-302
[3]
Vavvas D(2011)Utility values associated with vitreous floaters Am J Ophthalmol 152 60-65-e1
[4]
Wagle AM(2011)Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction Acta Ophthalmol 89 159-165
[5]
Lim WY(2015)Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction Acta Ophthalmol 89 159-165
[6]
Yap TP(2014)Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters Retina 34 1055-1061
[7]
Neelam K(2014)Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile Retina 34 1062-1068
[8]
Au Eong KG(2011)Safety of vitrectomy for floaters Am J Ophthalmol 151 995-998
[9]
Schulz-Key S(2001)Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters Bull Soc Belge Ophtalmol 280 15-19
[10]
Carlsson JO(2017)YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial JAMA Ophthalmol 135 918-923